CanniMed Therapeutics Inc (CMED) Insider Allan Mclay Fowler Sells 31,777 Shares

CanniMed Therapeutics Inc (TSE:CMED) insider Allan Mclay Fowler sold 31,777 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of C$31.81, for a total value of C$1,010,826.37.

Shares of CanniMed Therapeutics Inc (TSE:CMED) opened at C$35.52 on Thursday. The stock has a market capitalization of $879.36 and a P/E ratio of -31.71. CanniMed Therapeutics Inc has a 12-month low of C$7.32 and a 12-month high of C$46.00.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/02/15/cannimed-therapeutics-inc-cmed-insider-allan-mclay-fowler-sells-31777-shares.html.

CanniMed Therapeutics Company Profile

CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.

Insider Buying and Selling by Quarter for CanniMed Therapeutics (TSE:CMED)

Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply